Episode 32: Dr Sarah Glynne - hormones, the menopause and HRT
Listen now
Description
There may be a treatment from which a third of women with Long Covid could benefit.  It is not a new drug, it is safe, and it has been proven to work anecdotally.  And yet there are no clinical trials looking at HRT as a potential treatment for the largest cohort of Long Covid sufferers.  In our patriarchal medical system many women are not even being asked about their menstrual cycle or hormones in relation to Long Covid, and yet there is clear evidence that our hormones have been impacted.  This week, Dr Sarah Glynne, G.P. and menopause specialist, talks us through her research into Long Covid and the peri-menopause, and the prescribing of HRT as a treatment for Long Covid, which she believes shows tangible results.
More Episodes
Dr Theoharis Theoharides, aka “The Mast Cell Master”, has been exploring the world of Mast Cells, their influence on our bodily functions, neurology and genetic make up, for over half a century. The Director of the Center of Excellence for Neuroinflammation Research and Professor at the...
Published 06/11/24
Conor Browne, an independent Biorisk Consultant, analyses biosecurity risks for governmental bodies, commercial enterprises and NGOs, aiding with business continuity, forecasting and policy. He understood that Covid-19 was airborne in February 2020 but, he says, “it’s the first message that...
Published 05/23/24